Tilray | TRLY - DÍVIDA





DÍVIDA Alterar Data
Acasti Pharma USD 0 0 2024-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Avita Medical AUD 46.05M 1.46M 2025-12
Canopy Growth CAD 259.33M 68.47M 2025-09
Cronos Group USD 1.51M 233K 2025-12
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Moderna USD 1.31B 571M 2025-12
Organon & Co USD 8.64B 184M 2025-12
Revvity USD 3.4B 29.2M 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 14.34B 69.3M 2026-03
Xeris Pharmaceuticals USD 257.65M 431K 2025-09